Document Details

Filing Date
Jul 1, 2011
Document Date
Jul 1, 2011
Form Description
Registration of securities of foreign private issuers 12 (b) of the Securities Exchange Act
Filing Group
Registration Statements
Company
BioLineRx
Issuer
BioLineRx Ltd.
Shape
Potential life-changing treatments are on the way

Each molecule in our development pipeline is carefully selected for its potential ability to improve upon the standard of care, delivering maximum value to patients